STAAR Surgical
STAA
282 hedge funds and large institutions have $6.39B invested in STAAR Surgical in 2021 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 95 increasing their positions, 90 reducing their positions, and 18 closing their positions.
322% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 18
43% more capital invested
Capital invested by funds: $4.46B → $6.39B (+$1.93B)
25% more funds holding
Funds holding: 226 → 282 (+56)
6% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 90
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0% less call options, than puts
Call options by funds: $81.1M | Put options by funds: $81.2M
1.59% less ownership
Funds ownership: 91.02% → 89.42% (-1.6%)
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$185M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$59.6M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$31.7M |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
+$20.6M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$19.5M |
Top Sellers
| 1 |
BC
Broadwood Capital
New York
|
-$116M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$71.9M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$50.4M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$40.8M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$20.8M |
STAA Hedge Fund Activity: Q2 2021 in Review
282 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q2 2021, worth a combined $6.39B — up 43% from $4.46B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new STAA positions and 18 closed out — a net gain of 58 holders — while 95 added to existing stakes and 90 trimmed.
The largest buyer was Baillie Gifford & Co, adding an estimated $185M. The largest seller was Broadwood Capital, cutting an estimated $116M.
- 282 institutional investors held STAAR Surgical (STAA) as of Q2 2021, up from 226 in Q1 2021.
- Funds reported $6.39B of STAAR Surgical stock for Q2 2021, up 43% quarter-over-quarter.
- 76 funds opened new STAAR Surgical positions in Q2 2021 and 18 closed out, a net change of +58 holders.
- The largest STAAR Surgical buyer in Q2 2021 was Baillie Gifford & Co, an estimated $185M added.
- The largest STAAR Surgical seller in Q2 2021 was Broadwood Capital, an estimated $116M sold.
Based on aggregated 13F filings for Q2 2021.